Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25439278 | 1.00 | MAPT (0.52) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25439629 | 1.00 | MAPT (0.52) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30585013 | 0.90 | MAPT (0.46) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30584856 | 0.90 | MAPT (0.46) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL26306937 | 0.89 | MAPT (0.54) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25439251 | 0.89 | SMN1; SMN2 (0.62) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25438820 | 0.89 | SMN1; SMN2 (0.62) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25438827 | 0.89 | SMN1; SMN2 (0.62) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25438967 | 0.88 | SMN1; SMN2 (0.49) | MAPTLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30584737 | 0.88 | SMN1; SMN2 (0.49) | MAPTLMNAMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4463452-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |